Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Jeremy Niles Harris who wrote (811)	1/26/1998 6:33:00 AM
From: Harold Lehman	Respond to of 1501

You're right, it might be a stretch, unless the compound is lipid soluble. From conversations with Dr. Salari from previous years I believe that Apanol is not the most lipid soluble of their compounds; so far Tiesole is, but they're intending to first use it for topical applications. But regarding crossing of the blood brain barrier, here's another scenario. Apanol or another one of the products in development might greatly diminish the inflammatory response of antigen activated T cells that may cross the blood brain barrier to cause the disease and lessen it with passage of time.